Thermo Fisher Scientific Inc.
TMO
$427.50
-$9.29-2.13%
NYSE
| 12/31/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.05% | -2.42% | -2.71% | -3.00% | -4.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.05% | -2.42% | -2.71% | -3.00% | -4.58% |
| Cost of Revenue | -1.63% | 21.81% | 21.13% | 22.21% | 24.59% |
| Gross Profit | 4.94% | 23.92% | 24.08% | 21.31% | 12.90% |
| SG&A Expenses | 2.55% | 0.57% | -2.11% | -3.79% | -6.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 2,900.00% | -- | -- | -- | -- |
| Total Operating Expenses | -0.16% | 22.54% | 21.11% | 21.36% | 22.36% |
| Operating Income | 6.51% | 23.18% | 28.25% | 24.21% | 8.17% |
| Income Before Tax | 12.17% | 8.26% | 12.51% | 0.52% | -18.58% |
| Income Tax Expenses | 131.69% | 97.84% | 97.02% | 15.85% | -59.60% |
| Earnings from Continuing Operations | 6.47% | 3.36% | 8.05% | -0.61% | -14.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -110.00% | -22.22% | 780.00% | 587.50% | 500.00% |
| Net Income | 5.69% | 3.28% | 8.74% | 0.17% | -13.74% |
| EBIT | 6.51% | 23.18% | 28.25% | 24.21% | 8.17% |
| EBITDA | 1.58% | 21.64% | 26.35% | 24.41% | 13.09% |
| EPS Basic | 6.87% | 4.36% | 10.02% | 1.48% | -12.51% |
| Normalized Basic EPS | 7.80% | 1.19% | 7.38% | 3.34% | -12.97% |
| EPS Diluted | 6.99% | 4.69% | 10.37% | 1.79% | -12.24% |
| Normalized Diluted EPS | 7.86% | 1.31% | 7.58% | 3.46% | -12.79% |
| Average Basic Shares Outstanding | -1.10% | -1.03% | -1.16% | -1.28% | -1.40% |
| Average Diluted Shares Outstanding | -1.16% | -1.16% | -1.34% | -1.40% | -1.59% |
| Dividend Per Share | 11.43% | 12.59% | 13.85% | 15.20% | 16.67% |
| Payout Ratio | 0.05% | 0.10% | 0.05% | 0.15% | 0.33% |